Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and PEGPH20 in HA-high metastatic pancreatic cancer
NCT03634332Phase 2Unknown
- Sponsor
- Pancreatic Cancer Research Team
- Start
- May 2019
- Primary completion
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvorhyaluronidase alfa in pancreatic ductal adenocarcinoma (PDAC), sponsored by Pancreatic Cancer Research Team. Status: unknown.
02
Drugs
pegvorhyaluronidase alfa
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03634332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634332.